<DOC>
	<DOCNO>NCT01758978</DOCNO>
	<brief_summary>The primary objective study assess bioequivalence two 30-mg hydrocodone bitartrate extended-release tablet one 60-mg hydrocodone bitartrate extended-release tablet .</brief_summary>
	<brief_title>A Crossover Study Assess Bioequivalence Hydrocodone Bitartrate Extended-Release Tablet</brief_title>
	<detailed_description />
	<mesh_term>Hydrocodone</mesh_term>
	<criteria>Written inform consent obtain . The subject read , speak , write English . The subject man woman 18 45 year age , body mass index ( BMI ) 20.0 30.0 kg/m2 , inclusive . The subject good health determine medical psychiatric history , physical examination , ECG , serum chemistry , hematology , urinalysis , serology . Women must surgically sterile , 2 year postmenopausal , , childbearing potential , use acceptable method contraception , agree continue use method duration study 30 day discontinuation study drug . Acceptable method contraception include abstinence intrauterine device ( know failure rate le 1 % per year ) . The subject negative alcohol test urine drug screen ( UDS ) . The subject must willing able comply study restriction remain study center require duration study drug period study . The subject clinically significant uncontrolled medical condition ( treat untreated ) . The subject clinically significant deviation normal ECG physical examination finding , determine investigator medical monitor . The subject habitually consume , within past 2 year , 21 unit alcohol per week , history alcohol , narcotic , substance abuse define Diagnostic Statistical Manual Mental Disorder , Fourth Edition , Text Revision ( DSMIVTR , American Psychiatric Association 2000 ) . NOTE : A unit alcohol equal 1 ounce hard liquor , 5 ounce wine , 8 ounce beer . The subject pregnant lactate woman . ( Any woman become pregnant study withdrawn study . ) The subject disorder may interfere drug absorption , distribution , metabolism , excretion ( include gastrointestinal ( GI ) surgery ; history appendectomy allow ) . The subject receive investigational drug within 30 day 5 halflives ( whichever longer ) 1st dose study drug , case new chemical entity , 3 month 5 halflives ( whichever longer ) 1st dose study drug . The subject know sensitivity idiosyncratic reaction hydrocodone hydromorphone , related compound , metabolite , naltrexone , compound list present study formulation . Other exclusion criterion apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>bioequivalence , hydrocodone bitartrate extended-release tablet</keyword>
</DOC>